Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01947049 · ClinicalTrials.gov registry record · NA
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 2,011
- Enrollment target
NCT01947049: Completed NA study, sponsored by Johns Hopkins University.
NCT01947049 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 2,011 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01947049, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,011 participants
- Enrollment target
Study Summary
The purpose of this study is to: 1. Evaluate the clinical performance of a newly available highly-sensitive rapid influenza test, Xpert Flu. 2. Derive and validate an adult clinical decision guideline to guide clinical testing of influenza patients who meed CDC criteria for antiviral treatment. 3. Evaluate impact of rapid influenza testing for antiviral treatment. 4. Determine cost effectiveness of influenza testing and treatment strategies.
Interventions
- OTHER Rapid Influenza Testing with Xpert Flu
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,011 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01947049
The ClinicalTrials.gov registry entry for NCT01947049 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,011 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rapid Influenza Testing with Xpert Flu is the first listed.
NCT01947049 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01947049 about?
NCT01947049 is a clinical study titled "Influenza Diagnosis, Treatment and Surveillance With Xpert Flu". The purpose of this study is to: 1. Evaluate the clinical performance of a newly available highly-sensitive rapid influenza test, Xpert Flu. 2. Derive and validate an adult clinical decision guideline to guide clinical testing of influenza patients who meed CDC criteria for antiviral treatment. 3. ...
What is the current status of trial NCT01947049?
This trial is currently completed. It is a NA study. The enrollment target is 2,011 participants. The study started on 2013-07. Estimated completion is 2014-06-30.
What interventions are being tested in trial NCT01947049?
The interventions under investigation include: Rapid Influenza Testing with Xpert Flu (OTHER).
Who is sponsoring clinical trial NCT01947049?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.